Shinhung Co., Ltd (KRX:004080)
13,880
-20 (-0.14%)
At close: Oct 2, 2025
Shinhung Revenue
Shinhung had revenue of 24.54B KRW in the quarter ending June 30, 2025, a decrease of -1.76%. This brings the company's revenue in the last twelve months to 98.68B, down -8.15% year-over-year. In the year 2024, Shinhung had annual revenue of 101.76B, down -9.50%.
Revenue (ttm)
98.68B
Revenue Growth
-8.15%
P/S Ratio
1.33
Revenue / Employee
493.41M
Employees
200
Market Cap
131.18B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 101.76B | -10.69B | -9.50% |
Dec 31, 2023 | 112.44B | -5.73B | -4.85% |
Dec 31, 2022 | 118.18B | -8.68B | -6.84% |
Dec 31, 2021 | 126.85B | 10.20B | 8.74% |
Dec 31, 2020 | 116.65B | -6.36B | -5.17% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 5,031.69B |
Celltrion | 3,748.95B |
ALTEOGEN | 158.06B |
Yuhan | 2,165.44B |
SK Biopharmaceuticals | 620.28B |
Peptron | 5.18B |
PharmaResearch | 449.81B |
LigaChem Biosciences | 148.28B |